The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma-Reference-Cited by-同舟云学术

The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma

Published:2016-09-08 Issue:2 Volume:41 Page:480-486
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J Surg

Author:

Hiyoshi Yukiharu,Yoshida Naoya,Watanabe Masayuki,Kurashige Junji,Baba Yoshifumi,Sakamoto Yasuo,Baba Hideo

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00268-016-3649-0.pdf

Reference43 articles.

1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

2. Allum WH, Stenning SP, Bancewicz J et al (2009) Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol Off J Am Soc Clin Oncol 27(5062–506):7

3. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial Lancet (London, England) (2002): 359; 1727–1733

4. van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. New Engl J Med 366(2074–208):4

5. Ando N, Iizuka T, Ide H et al (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study–JCOG9204. J Clin Oncol Off J Am Soc Clin Oncol 21:4592–4596

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indications for neoadjuvant chemotherapy in older patients undergoing esophagectomy for esophageal cancer;Surgery Today;2023-10-31

2. Platelet-to-Lymphocyte Ratio Multiplied by the Cytokeratin-19 Fragment Level as a Predictor of Pathological Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma;Yonago Acta Medica;2021

3. GASC1-Adapted Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma: A Prospective Clinical Biomarker Trial;Journal of Oncology;2020-01-30

4. Specifics 1: Head and Neck Cancer and Esophageal Cancer;Biomarkers in Cancer Therapy;2019

5. Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinoma;Esophagus;2018-06-29